HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adults.

Abstract
Cytomegalovirus (CMV) has been implicated in vascular pathologies and may warrant inclusion in cardiovascular predictive algorithms. We addressed this in healthy older adults and renal transplant recipients (RTR) as they retain a high burden of CMV. RTR (n  =  45) stable more than 2 years after transplantation and 58 age-matched healthy adults were assessed. Plasma inflammatory biomarkers (soluble isoform of the interferon-β receptor [sIFNAR2], soluble tumour necrosis factorreceptor-1 [sTNFR1], soluble cluster of differentiation 14 [sCD14], C reactive protein, P-selectin, intracellular cell adhesion molecule-1, vascular cell adhesion molecule-1), and measures of CMV burden (antibodies, saliva CMV DNA, and interferon γ responses to CMV) were assessed in 2014 and evaluated in 2017 as predictors of vascular health-defined using flow-mediated dilatation (FMD), pulse wave velocity (PWV), and augmentation indices (Aix@ 75). Linear regression models adjusted for age, sex, and body mass index (BMI) were optimized to identify risk factors. In 2017, RTR had inferior vascular health marked by impaired FMD and PWV. Detectable CMV DNA (P = .02) was associated with impaired FMD, whilst CMV glycoprotein B (gB) antibody attenuated this effect (P  =  .03) (adjusted R2  =  .42). In healthy adults, the optimal model for predicting FMD (R2  =.22) incorporated high P-selectin (P  =  .03) and low ICAM-1 (P  = .03) levels with no significant impact of CMV. Elevated sIFNAR2 (P  = .04) and gB antibody (P  =  .06) levels predicted increasing Aix@ 75 (poor vascular health) in healthy adults (R2  =  .4), whilst optimal models for RTR (R2  =  .37) linked low sIFNAR2 and CMV IE-1 antibody levels with lower Aix@ 75 (better vascular health). CMV IE-1 antibody was also protective in relation to PWV in healthy adults (R2  =  .55). Overall, measures of active CMV replication were more predictive of impaired FMD in RTR than standard biomarkers, but increased CMV gB antibodies may be protective.
AuthorsJacquita S Affandi, Silvia Lee, HuiJun Chih, Emily Brook, Shelley Waters, Prue Howson, Christopher M Reid, Ashley Irish, Patricia Price
JournalJournal of medical virology (J Med Virol) Vol. 92 Issue 12 Pg. 3650-3657 (Dec 2020) ISSN: 1096-9071 [Electronic] United States
PMID32017150 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 Wiley Periodicals, Inc.
Chemical References
  • Biomarkers
  • Antibodies, Viral
  • DNA, Viral
Topics
  • Humans
  • Male
  • Kidney Transplantation (adverse effects)
  • Female
  • Middle Aged
  • Cytomegalovirus (immunology)
  • Cytomegalovirus Infections (virology, blood)
  • Transplant Recipients
  • Biomarkers (blood)
  • Adult
  • Aged
  • Risk Factors
  • Pulse Wave Analysis
  • Antibodies, Viral (blood)
  • Cardiovascular Diseases (virology)
  • DNA, Viral (blood)
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: